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The epoc
s
blood analysis system (Epocal Inc., Ottawa, Ontario,
Canada) is a newly developed in vitro diagnostic hand-held ana-
lyzer for testing whole blood samples at point-of-care, which
provides blood gas, electrolytes, ionized calcium, glucose, lactate,
and hematocrit/calculated hemoglobin rapidly. The analytical
performance of the epoc
s
system was evaluated in a tertiary
hospital, see related research article “Analytical evaluation of the
epoc
s
point-of-care blood analysis system in cardiopulmonary
bypass patients” [1]. Data presented are the linearity analysis for
9 parameters and the comparison study in 40 cardiopulmonary
bypass patients on 3 epoc
s
meters, Instrumentation Laboratory
GEM4000, Abbott iSTAT, Nova CCX, and Roche Accu-Chek Inform II
and Performa glucose meters.
& 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).vier Inc. This is an open access article under the CC BY license
ratory Medicine, Dr. Everett Chalmers Regional Hospital, Horizon Health
).
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ject areaPoint-of-care testingype of data Figure
ow data was
acquiredThe epoc
s
blood analysis system (Epocal Inc., Ottawa, Ontario, Canada)ata format Analyze data
xperimental
factorsPatients under cardiopulmonary bypass were all heparinized as routinexperimental
featuresLinearity was evaluated using 5 levels of Eurotrol epoc Calibration Veriﬁca-
tion Fluids and 5 levels of Eurotrol epoc Hematocrit Veriﬁcation Fluids
(Eurotrol B.V., Keplerlaan, The Netherlands) on 3 epoc
s
blood analysis sys-
tems. Linearity materials were analyzed in triplicate on each system. Rem-
nant specimens from cardiopulmonary bypass patients collected in plain
3 mL syringe for routine clinical analysis on GEM4000 in the cardiovascular
operating room were used. After being analyzed on GEM4000 and all 3 epoc
meters, samples were analyzed in Abbott iSTAT, Nova CCX analyzer, Roche
Accu-Chek Inform II and Performa glucose meters side by side, with all
measurements performed within 5 min.ata source
locationSaint John, New Brunswick, Canadaata accessibility Data are within this articleValue of the data Detailed analytical linearity analysis for 9 parameters on the epocs meters was presented.
 Comparison study was conducted on 40 cardiopulmonary bypass patients.
 The data helps medical laboratories and point-of-care testing users to make an informed decision
on blood gas analyzer selection.1. Data
The data contains information on the analytical linearity performances for 9 parameters on
3 epoc
s
meters (Supplementary Fig. 1). It also contains information on the cardiopulmonary bypass
patient sample comparison study for analytical accuracy performance for 8 parameters on 3 epoc
s
meters (Figs. 1–4).2. Experimental design, materials and methods
2.1. The epoc
s
blood analysis system
The epoc
s
blood analysis system (Epocal Inc., Ottawa, Ontario, Canada) is a newly developed hand-
held analyzer for testing whole blood samples at point-of-care, which provides blood gas, electrolytes,
ionized calcium, glucose, lactate, and hematocrit/calculated hemoglobin in 30 seconds. This system
contains a test card, a wireless card reader, and a host mobile computer. pH, pCO2, sodium, potassium,
and ionized calcium are measure potentiometrically; pO2, glucose, and lactate are measured amper-
ometrically, whereas hematocrit is determined conductometrically [2]. Hemoglobin is calculated from
Fig. 1. The comparison study of the epoc
s
point-of-care blood analysis system with the GEM4000 in cardiopulmonary bypass
patients.
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Fig. 2. The comparison study of the epoc
s
point-of-care blood analysis system with the iSTAT in cardiopulmonary bypass
patients.
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Fig. 4. The comparison study of the epoc
s
point-of-care blood analysis system with the Roche glucose meters in cardio-
pulmonary bypass patients.
Fig. 3. The comparison study of the epoc
s
point-of-care blood analysis system with the Nova CCX in cardiopulmonary bypass
patients.
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[3,4].
2.2. Linearity study
The epoc
s
point-of-care blood analysis system was evaluated using several Clinical and Laboratory
Standards Institute (CLSI) evaluation protocols for testing the linearity (EP6) [5]. Five levels of Eurotrol
epoc Calibration Veriﬁcation Fluids (Eurotrol B.V., Keplerlaan, The Netherlands, lot183-B407), and
5 levels of Eurotrol epoc Hematocrit Veriﬁcation Fluids (Eurotrol B.V., Keplerlaan, The Netherlands,
lot190-B404) were measured on all three epoc
s
blood analysis systems. These linearity materials
were analyzed in triplicate on each system respectively.
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The epoc
s
point-of-care blood analysis system was evaluated using several Clinical and Laboratory
Standards Institute (CLSI) evaluation protocols for testing the accuracy (EP15) [6] and bias (EP9) [7].
Remnant specimens from 40 heparinized CPB patients collected in plain 3 mL syringe (Becton Dick-
inson, Franklin Lakes, New Jersey) for routine clinical analysis on GEM4000 (Instrumentation
Laboratory, Bedford, MA, USA) in the cardiovascular operating room of the Saint John Regional
Hospital, Horizon Health Network, were used for this study. Samples collected were of arterial, mixed
venous, and venous types. After being analyzed on GEM4000 and all 3 epoc meters (therefore total
epoc
s
measurements were up to 118), samples were analyzed in Abbott iSTAT (Abbott Point of Care,
Princeton, NJ, USA), Nova CCX analyzer (Nova Biomedical Corporation, Waltham, MA, USA), Accu-
Chek Inform II and Performa glucose meters (Roche Diagnostics, Basel, Switzerland) side by side, with
all measurements performed within 5 min. All testing devices were run according to manufacturers’
instructions by a medical laboratory technologist. These arrangements attempted to eliminate pre-
analytical errors associated with blood analysis, such as different sample collection containers and
sensitive specimen stability [8,9].
2.4. Statistical method
Statistical analysis was carried out using Microsoft Excel. The best ﬁt line by linear regressionwas used
to evaluate assay linearity (Supplementary Fig. 1). Regression analysis was used to evaluate method
comparisons (Figs. 1–4). Bland–Altman analysis was constructed to assess systematic bias between
methods (see Ref. [1]). Comparison studies on hemoglobin measurements see Fig. 1 in Ref. [1].Appendix A. Supplementary material
Supplementary data associated with this article can be found in the online version at http://dx.doi.
org/10.1016/j.dib.2016.01.040.References
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